JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (90)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hendriks, H. G. D.
Right arrow Articles by van der Meer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hendriks, H. G. D.
Right arrow Articles by van der Meer, J.
Related Collections
Right arrow Blood
Right arrow Heart
Anesth Analg 2001;93:287-289
© 2001 International Anesthesia Research Society

CARDIOVASCULAR ANESTHESIA

An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII

Herman G. D. Hendriks, MD*, Joost M. A. A. van der Maaten, MD*, Joost de Wolf, MD, PhD{dagger}, Tjalling W. Waterbolk, MD{ddagger}, Maarten J. H. Slooff, MD, PhD§, and Jan van der Meer, MD, PhD||||

Departments of *Anesthesiology, {dagger}Hematology, {ddagger}Thoracic Surgery, §Hepatobiliary Surgery and Liver Transplantation, and the ||||Division of Hemostasis, Thrombosis and Rheology, University Hospital, Groningen, The Netherlands

Address correspondence and reprint requests to H. G. D. Hendriks, MD, Groningen University Hospital, Department of Anesthesiology, Hanzeplein 1, PO Box 30.001, 9700 RB Groningen, The Netherlands. Address e-mail to h.g.d.hendriks{at}anest.azg.nl

IMPLICATIONS: The successful treatment with recombinant factor VIIa of a patient experiencing intractable bleeding after cardiac surgery is described.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
K. A. Tanaka, T. Taketomi, F. Szlam, A. Calatzis, and J. H. Levy
Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven(R)) and Fibrinogen (Haemocomplettan(R) P)
Anesth. Analg., March 1, 2008; 106(3): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O. Warren, K. Mandal, V. Hadjianastassiou, L. Knowlton, S. Panesar, K. John, A. Darzi, and T. Athanasiou
Recombinant Activated Factor VII in Cardiac Surgery: A Systematic Review
Ann. Thorac. Surg., February 1, 2007; 83(2): 707 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Jaggers and J. H. Lawson
Coagulopathy and Inflammation in Neonatal Heart Surgery: Mechanisms and Strategies
Ann. Thorac. Surg., June 1, 2006; 81(6): S2360 - S2366.
[Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
J.-F. Hardy, P. de Moerloose, C. M. Samama, and Members of the Groupe d'Interet en Hemostase Perio
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management: [Transfusion massive et coagulopathie-: physiopathologie et implications cliniques].
Can J Anesth, June 1, 2006; 53(6_suppl): S40 - S58.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Romagnoli, S. Bevilacqua, S. Gelsomino, S. Pradella, L. Ghilli, C. Rostagno, G. F. Gensini, and C. Sorbara
Small-Dose Recombinant Activated Factor VII (NovoSeven(R)) in Cardiac Surgery.
Anesth. Analg., May 1, 2006; 102(5): 1320 - 1326.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
J. Ballen, M. Raabe, and B. Muirhead
Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?: [Dissection aortique et asystolie sous hypothermie chez un Temoin de Jehovah : un cas pour le facteur VIIa recombinant ?].
Can J Anesth, April 1, 2006; 53(4): 353 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
J. H. Levy
Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation
Am. J. Health Syst. Pharm., September 15, 2005; 62(18_Supplement_4): S15 - S19.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
M. Hyllner, E. Houltz, and A. Jeppsson
Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery
Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 254 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. Raivio, R. Suojaranta-Ylinen, and A. H. Kuitunen
Recombinant Factor VIIa in the Treatment of Postoperative Hemorrhage After Cardiac Surgery
Ann. Thorac. Surg., July 1, 2005; 80(1): 66 - 71.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. J. DiDomenico, M. G. Massad, J. Kpodonu, R. A. Navarro, and A. S. Geha
Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary Bypass
Chest, May 1, 2005; 127(5): 1828 - 1835.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. S. Lam and R. P Sims-McCallum
Recombinant Factor VIIa in the Treatment of Non-Hemophiliac Bleeding
Ann. Pharmacother., May 1, 2005; 39(5): 885 - 891.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
Canadian Anesthesiologists' Society Annual Meeting: Award-Winning Abstracts
Can J Anesth, December 1, 2004; 51(10): A1 - A10.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. M. Mahdy and N. R. Webster
Perioperative systemic haemostatic agents
Br. J. Anaesth., December 1, 2004; 93(6): 842 - 858.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. D Flynn, M. Pajoumand, P. C Camp Jr, M S. Jahania, C. Ramaiah, and W. S Akers
Recombinant Factor VIIa for Refractory Bleeding Following Orthotopic Heart Transplantation
Ann. Pharmacother., October 1, 2004; 38(10): 1639 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
J. D. Tobias, J. M. Simsic, S. Weinstein, W. Schechter, V. Kartha, and R. Michler
Recombinant Factor VIIa to Control Excessive Bleeding Following Surgery for Congenital Heart Disease in Pediatric Patients
J Intensive Care Med, September 1, 2004; 19(5): 270 - 273.
[Abstract] [PDF]

Home page
 Anesth. Analg.Home page
T. Szabo, S. Ali, and E. M. Camporesi
Intraoperative Recombinant Activated Factor VII for Emergent Epidural Hematoma Evacuation
Anesth. Analg., August 1, 2004; 99(2): 595 - 597.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. R. McIlroy and A. J. Silvers
Recombinant Factor VIIa for Life-Threatening Bleeding in High-Risk Cardiac Surgery Despite Full-Dose Aprotinin
Anesth. Analg., July 1, 2004; 99(1): 27 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
G. Stratmann, A. M. deSilva, E. E. Tseng, J. Hambleton, M. Balea, A. J. Romo, M. J. Mann, N. L. Achorn, W. F. Moskalik, and C. W. Hoopes
Reversal of Direct Thrombin Inhibition After Cardiopulmonary Bypass in a Patient with Heparin-Induced Thrombocytopenia
Anesth. Analg., June 1, 2004; 98(6): 1635 - 1639.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
T. S. Chhina, H. Lapierre, Z. S. Jackson, H. M. Leong-Poi, J. M. Teitel, D. A. Latter, B. H. Strauss, P. L. Gross, and C. D. Mazer
Effect of Recombinant Factor VIIa on Rabbit Vascular Graft Patency
Can J Anesth, June 1, 2004; 51(suppl_1): A1 - A1.
[Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
J.-F. Hardy, P. de Moerloose, M. Samama, and members of the Groupe d'interet en Hemostase Perio
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management: [Transfusion massive et coagulopathie : physiopathologie et implications cliniques]
Can J Anesth, April 1, 2004; 51(4): 293 - 310.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. Stratmann, I. A. Russell, and S. H. Merrick
Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair
Ann. Thorac. Surg., December 1, 2003; 76(6): 2094 - 2097.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
V. N. Naik, C. D. Mazer, D. A. Latter, J. M. Teitel, and G. M.T. Hare
Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass: [La reussite d'un traitement avec le facteur VIIa recombinant pour un saignement abondant apres la circulation extracorporelle]
Can J Anesth, June 1, 2003; 50(6): 599 - 602.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. L. Mindikoglu, A. Anantharaju, J. Villanueva, N. Shah, and D. H. Van Thiel
Pericardiocentesis and Pancreatic Aspiration Needle Biopsy in Coagulopathic and Thrombocytopenic Cirrhotic Patient
Chest, March 1, 2003; 123(3): 956 - 958.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Kastrup, C. von Heymann, H. Hotz, W. F. Konertz, S. Ziemer, W. J. Kox, and C. Spies
Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta
Ann. Thorac. Surg., September 1, 2002; 74(3): 910 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
W. Dietrich, M. Spannagl, H. G. D. Hendriks, J. M. A. A. van der Maaten, J. Th. M. de Wolf, and J. van der Meer
Caveat Against the Use of Activated Recombinant Factor VII for Intractable Bleeding in Cardiac Surgery * Response
Anesth. Analg., May 1, 2002; 94(5): 1369 - 1371.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.